197 related articles for article (PubMed ID: 24881517)
1. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
Pollack CV; Levy JH; Eikelboom J; Weitz JI; Sellke FW; Huisman MV; Steiner T; Kamphuisen P; Bernstein RA
Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
[No Abstract] [Full Text] [Related]
3. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
5. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Brunetti L; Chen C; White J
Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
[TBL] [Abstract][Full Text] [Related]
7. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
[No Abstract] [Full Text] [Related]
8. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
9. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
[TBL] [Abstract][Full Text] [Related]
10. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
11. Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
Atay JK; Fanikos J; Barnes GD; Ehle M; Coatney J; Piazza G; Froehlich JB; Goldhaber SZ
Am J Cardiol; 2013 Aug; 112(3):387-9. PubMed ID: 23647794
[TBL] [Abstract][Full Text] [Related]
12. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
[No Abstract] [Full Text] [Related]
13. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
Chevalier J; Giroud M; de Pouvourville G
Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
[TBL] [Abstract][Full Text] [Related]
14. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
[TBL] [Abstract][Full Text] [Related]
15. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
16. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
Zotova IV; Zateĭshchikov DA
Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
[No Abstract] [Full Text] [Related]
17. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
[TBL] [Abstract][Full Text] [Related]
18. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P
Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
Marrone LC; Marrone AC
Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
[No Abstract] [Full Text] [Related]
20. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
Barrios V; Escobar C
Expert Opin Pharmacother; 2012 Dec; 13(18):2649-61. PubMed ID: 23167273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
